Log in

NYSEAMERICAN:SYNSynthetic Biologics News Headlines

$0.60
-0.01 (-1.91 %)
(As of 08/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.58
Now: $0.60
$0.65
50-Day Range N/A
52-Week Range
$0.25
Now: $0.60
$0.75
Volume798,479 shs
Average Volume437,654 shs
Market Capitalization$10.96 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Synthetic Biologics (NYSEAMERICAN SYN) News Headlines

Source:
DateHeadline
Synthetic Biologics (NYSEAMERICAN:SYN) Trading Up 7.3%Synthetic Biologics (NYSEAMERICAN:SYN) Trading Up 7.3%
americanbankingnews.com - August 4 at 7:31 PM
Synthetic Biologics (NYSEAMERICAN:SYN) Shares Gap Down to $0.58Synthetic Biologics (NYSEAMERICAN:SYN) Shares Gap Down to $0.58
americanbankingnews.com - August 3 at 4:28 PM
58 Stocks Moving In Thursdays Regular-Market Session58 Stocks Moving In Thursday's Regular-Market Session
www.benzinga.com - August 1 at 8:08 PM
Synthetic Biologics (NYSEAMERICAN:SYN)  Shares Down 18.6% Synthetic Biologics (NYSEAMERICAN:SYN) Shares Down 18.6%
www.americanbankingnews.com - July 31 at 8:51 PM
Synthetic Biologics (NYSEAMERICAN:SYN) Shares Gap Up to $0.54Synthetic Biologics (NYSEAMERICAN:SYN) Shares Gap Up to $0.54
www.americanbankingnews.com - July 30 at 8:29 PM
Synthetic Biologics (SYN) to Release Earnings on ThursdaySynthetic Biologics (SYN) to Release Earnings on Thursday
www.americanbankingnews.com - July 30 at 9:33 AM
Synthetic Biologics (NYSEAMERICAN:SYN)  Shares Down 1.8% Synthetic Biologics (NYSEAMERICAN:SYN) Shares Down 1.8%
www.americanbankingnews.com - July 24 at 12:12 AM
BRIEF-Synthetic Biologics Announces Submission Of Ind Application To U.S. FDA For Syn-020 Intestinal Alkaline PhosphataseBRIEF-Synthetic Biologics Announces Submission Of Ind Application To U.S. FDA For Syn-020 Intestinal Alkaline Phosphatase
www.reuters.com - June 30 at 9:01 AM
Synthetic Biologics Announces Submission of IND Application to U.S. FDA for SYN-020 Intestinal Alkaline PhosphataseSynthetic Biologics Announces Submission of IND Application to U.S. FDA for SYN-020 Intestinal Alkaline Phosphatase
finance.yahoo.com - June 30 at 9:01 AM
Synthetic Biologics Enters into Exclusive Option to License Intellectual Property for Use of SYN-020 to Treat and Prevent Age-Related Metabolic and Inflammatory DiseasesSynthetic Biologics Enters into Exclusive Option to License Intellectual Property for Use of SYN-020 to Treat and Prevent Age-Related Metabolic and Inflammatory Diseases
finance.yahoo.com - May 27 at 7:04 AM
Edited Transcript of SYN earnings conference call or presentation 5-May-20 8:30pm GMTEdited Transcript of SYN earnings conference call or presentation 5-May-20 8:30pm GMT
finance.yahoo.com - May 14 at 11:58 PM
Sýn hf.: Q1 2020 affected by the COVID-19 pandemicSýn hf.: Q1 2020 affected by the COVID-19 pandemic
finance.yahoo.com - May 13 at 12:42 PM
BRIEF-Synthetic Biologics Reports Qtrly Loss Per Share $0.20BRIEF-Synthetic Biologics Reports Qtrly Loss Per Share $0.20
www.reuters.com - May 5 at 11:53 PM
Synthetic Biologics (SYN) CEO Steven Shallcross on Q1 2020 Results - Earnings Call TranscriptSynthetic Biologics' (SYN) CEO Steven Shallcross on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 5 at 11:53 PM
Synthetic Biologics to Report 2020 First Quarter Operational Highlights and Financial Results on May 5, 2020Synthetic Biologics to Report 2020 First Quarter Operational Highlights and Financial Results on May 5, 2020
finance.yahoo.com - April 28 at 6:41 PM
Results in line with outlookResults in line with outlook
finance.yahoo.com - February 26 at 2:30 PM
Edited Transcript of SYN earnings conference call or presentation 20-Feb-20 9:30pm GMTEdited Transcript of SYN earnings conference call or presentation 20-Feb-20 9:30pm GMT
finance.yahoo.com - February 23 at 5:05 PM
Synthetic Biologics Announces Acceptance of Compliance Plan by NYSE AmericanSynthetic Biologics Announces Acceptance of Compliance Plan by NYSE American
finance.yahoo.com - February 7 at 5:41 PM
We Think Synthetic Biologics (NYSEMKT:SYN) Needs To Drive Business Growth CarefullyWe Think Synthetic Biologics (NYSEMKT:SYN) Needs To Drive Business Growth Carefully
finance.yahoo.com - February 6 at 3:17 PM
Synthetic Biologics to Present at the 2020 BIO CEO & Investor ConferenceSynthetic Biologics to Present at the 2020 BIO CEO & Investor Conference
www.prnewswire.com - February 4 at 7:30 AM
Synthetic Bio up 9% on advancement of co-lead candidateSynthetic Bio up 9% on advancement of co-lead candidate
seekingalpha.com - January 7 at 4:11 PM
BRIEF-Synthetic Biologics Receives FDA Guidance At Type C Meeting For SYN-004 (Ribaxamase) Phase 1B/2A Clinical Trial In Allogeneic HCT RecipientsBRIEF-Synthetic Biologics Receives FDA Guidance At Type C Meeting For SYN-004 (Ribaxamase) Phase 1B/2A Clinical Trial In Allogeneic HCT Recipients
www.msn.com - January 7 at 8:05 AM
Synthetic Biologics Receives FDA Guidance at Type C Meeting for SYN-004 (ribaxamase) Phase 1b/2a Clinical Trial in Allogeneic HCT RecipientsSynthetic Biologics Receives FDA Guidance at Type C Meeting for SYN-004 (ribaxamase) Phase 1b/2a Clinical Trial in Allogeneic HCT Recipients
finance.yahoo.com - January 7 at 8:05 AM
Sýn hf.: Financial calendar 2020Sýn hf.: Financial calendar 2020
finance.yahoo.com - December 30 at 6:44 AM
Biologic Response Modifiers Market to Gain a Stronghold by 2027Biologic Response Modifiers Market to Gain a Stronghold by 2027
www.marketwatch.com - December 11 at 8:02 AM
Is Synthetic Biologics Inc (SYN) Going To Burn These Hedge Funds ?Is Synthetic Biologics Inc (SYN) Going To Burn These Hedge Funds ?
finance.yahoo.com - November 30 at 11:22 AM
BRIEF-Synthetic Biologics Reports On NYSE American Noncompliance Notice And Compliance PlanBRIEF-Synthetic Biologics Reports On NYSE American Noncompliance Notice And Compliance Plan
www.msn.com - November 27 at 11:36 PM
Sýn hf.: Landsdowne Partners International Limited - Major shareholder announcementsSýn hf.: Landsdowne Partners International Limited - Major shareholder announcements
finance.yahoo.com - November 14 at 1:43 PM
Sýn hf.: Best operating profit of the yearSýn hf.: Best operating profit of the year
finance.yahoo.com - November 6 at 1:02 PM
Multiple Sclerosis Market Size Growth Forecasts to 2027 – Sanofi, Teva Pharmaceutical, Bayer, Pfizer, Synthetic BiologicMultiple Sclerosis Market Size Growth Forecasts to 2027 – Sanofi, Teva Pharmaceutical, Bayer, Pfizer, Synthetic Biologic
www.marketwatch.com - October 1 at 12:22 PM
Synthetic Biologics, Inc (SYN) CEO Steven Shallcross on Q2 2019 Results - Earnings Call TranscriptSynthetic Biologics, Inc (SYN) CEO Steven Shallcross on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 5:19 AM
NanoFUSE Biologics a One of a Kind Bioactive Glass and DBM Expands into PanamaNanoFUSE Biologics a One of a Kind Bioactive Glass and DBM Expands into Panama
finance.yahoo.com - August 7 at 8:01 AM
Synthetic Biologics Regains Compliance with NYSE American Continued Listing StandardsSynthetic Biologics Regains Compliance with NYSE American Continued Listing Standards
finance.yahoo.com - July 1 at 9:07 AM
Synthetic Biologics (SYN) CEO Steven Shallcross on Q1 2019 Results - Earnings Call TranscriptSynthetic Biologics' (SYN) CEO Steven Shallcross on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 10:22 AM
Edited Transcript of SYN earnings conference call or presentation 8-May-19 8:30pm GMTEdited Transcript of SYN earnings conference call or presentation 8-May-19 8:30pm GMT
finance.yahoo.com - May 9 at 10:22 AM
Synthetic Biologics to Report 2019 First Quarter Operational Highlights and Financial Results on May 8, 2019Synthetic Biologics to Report 2019 First Quarter Operational Highlights and Financial Results on May 8, 2019
finance.yahoo.com - April 30 at 5:10 PM
Global Human Microbiome Markets, 2024 - Yakult, DuPont, Series Therapeutics, Second Genome, and Synthetic Biologics Hold Substantial Market ShareGlobal Human Microbiome Markets, 2024 - Yakult, DuPont, Series Therapeutics, Second Genome, and Synthetic Biologics Hold Substantial Market Share
www.prnewswire.com - April 4 at 11:23 AM
Synthetic Biologics Reports 2018 Year End Operational Highlights and Financial Results - PRNewswireSynthetic Biologics Reports 2018 Year End Operational Highlights and Financial Results - PRNewswire
www.prnewswire.com - February 27 at 5:15 PM
Sýn hf. : Sýn finalizes the merger of Hey P/F with Nema P/FSýn hf. : Sýn finalizes the merger of Hey P/F with Nema P/F
finance.yahoo.com - February 26 at 11:06 AM
Synthetic Biologics to Report 2018 Year End Operational Highlights and Financial Results on February 27, 2019Synthetic Biologics to Report 2018 Year End Operational Highlights and Financial Results on February 27, 2019
finance.yahoo.com - February 19 at 5:07 PM
Synthetic Biologics Announces First Two Patients Enrolled in Phase 2b Investigator-SponsoredSynthetic Biologics Announces First Two Patients Enrolled in Phase 2b Investigator-Sponsored
finance.yahoo.com - January 3 at 9:23 AM
This page was last updated on 8/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.